VRDN Institutional Ownership & Shareholders

VIRIDIAN THERAPEUTICS INC (VRDN) is currently held by 212 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $2.50B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

Fmr Llc is currently the largest disclosed institutional shareholder of VRDN tracked by InsiderSet, reporting ownership valued at approximately $305.03M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $420.10M, representing an estimated gain of +37.72% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 52% of the total disclosed VRDN value among the investors covered in this analysis. Major shareholders include Fmr Llc, Blackrock, Inc., Bellevue Group Ag, and several other long-term asset managers with concentrated positions in VIRIDIAN THERAPEUTICS INC (VRDN).

This page ranks the largest institutional VRDN shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

212

Total Reported Value

$2.50B

Largest Holder

Fmr Llc

Largest Position

$305.03M

Insider Transactions (90d)

3

Latest Filing Quarter

Q2 2026

New Institutional Positions

73

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Fmr Llc0.01%16,604,740$305,029,074$420,099,922+$115,070,848+37.72%
Blackrock, Inc.0.00%8,551,488$157,090,835$216,352,646+$59,261,811+37.72%
Bellevue Group Ag2.60%6,731,909$123,665,169$170,317,298+$46,652,129+37.72%
Paradigm Biocapital Advisors Lp2.31%6,723,788$123,515,986$170,111,836+$46,595,850+37.72%
Kynam Capital Management, Lp6.55%6,453,877$118,557,720$163,283,088+$44,725,368+37.72%
State Street Corp0.00%6,124,976$112,515,809$154,961,893+$42,446,084+37.72%
Price T Rowe Associates Inc0.01%5,748,410$105,599,000$145,434,773+$39,835,773+37.72%
Fairmount Funds Management Llc6.18%5,090,928$93,520,347$128,800,478+$35,280,131+37.72%
Vanguard Capital Management Llc0.00%4,576,860$84,076,918$115,794,558+$31,717,640+37.72%
Deep Track Capital, Lp0.97%3,592,740$65,998,634$90,896,322+$24,897,688+37.72%
Venrock Adviser, Llc1.81%3,257,917$59,847,935$82,425,300+$22,577,365+37.72%
Wellington Management Group Llp0.01%3,128,362$57,468,009$79,147,559+$21,679,550+37.72%
Vanguard Portfolio Management Llc0.00%2,752,827$50,569,432$69,646,523+$19,077,091+37.72%
Geode Capital Management, Llc0.00%2,501,869$45,968,039$63,297,286+$17,329,247+37.70%
Avoro Capital Advisors Llc0.41%2,500,000$45,925,000$63,250,000+$17,325,000+37.72%
Baker Bros. Advisors Lp0.22%2,383,025$43,776,169$60,290,533+$16,514,364+37.72%
Point72 Asset Management, L.P.0.07%2,343,208$43,044,731$59,283,162+$16,238,431+37.72%
Caligan Partners Lp1.94%2,193,981$40,303,431$55,507,719+$15,204,288+37.72%
Novo Holdings A/S2.28%2,135,000$39,219,950$54,015,500+$14,795,550+37.72%
Tang Capital Management Llc1.50%1,792,626$32,930,540$45,353,438+$12,422,898+37.72%
Fisher Asset Management, Llc0.01%1,750,850$32,163,113$44,296,505+$12,133,392+37.72%
Candriam S.C.A.0.14%1,526,806$31,551,795$38,628,192+$7,076,397+22.43%
Goldman Sachs Group Inc0.00%1,691,304$31,069,254$42,789,991+$11,720,737+37.72%
First Turn Management, Llc3.28%1,670,000$30,677,900$42,251,000+$11,573,100+37.72%
Dimensional Fund Advisors Lp0.01%1,611,521$29,607,274$40,771,481+$11,164,207+37.71%
Alliancebernstein L.P.0.01%1,391,639$27,220,459$35,208,467+$7,988,008+29.35%
Ubs Group Ag0.00%1,428,843$26,247,845$36,149,728+$9,901,883+37.72%
Parkman Healthcare Partners Llc2.60%1,377,576$25,306,071$34,852,673+$9,546,602+37.72%
Balyasny Asset Management L.P.0.04%1,279,859$23,511,010$32,380,433+$8,869,423+37.72%
D. E. Shaw & Co., Inc.0.01%1,182,222$21,717,418$29,910,217+$8,192,799+37.72%
Rice Hall James & Associates, Llc1.05%1,175,906$21,601,393$29,750,422+$8,149,029+37.72%
Arrowstreet Capital, Limited Partnership0.01%1,112,413$20,435,027$28,144,049+$7,709,022+37.72%
Bnp Paribas Financial Markets0.01%1,012,138$18,592,975$25,607,091+$7,014,116+37.72%
Elmind Capital, Lp4.55%984,931$18,093,182$24,918,754+$6,825,572+37.72%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc0.00%888,298$17,375,111$22,473,939+$5,098,828+29.35%
Bank Of America Corp0.00%944,345$17,347,618$23,891,929+$6,544,311+37.72%
Northern Trust Corp0.00%863,491$15,862,330$21,846,322+$5,983,992+37.72%
Eversept Partners, Lp0.83%831,142$15,268,079$21,027,893+$5,759,814+37.72%
Charles Schwab Investment Management Inc0.00%815,027$14,972,046$20,620,183+$5,648,137+37.72%
Schonfeld Strategic Advisors Llc0.08%793,508$14,576,741$20,075,752+$5,499,011+37.72%
Renaissance Technologies LLCJim Simons0.02%768,600$14,119,182$19,445,580+$5,326,398+37.72%
Morgan Stanley0.00%728,817$13,388,384$18,439,070+$5,050,686+37.72%
Woodline Partners Lp0.04%700,929$12,876,066$17,733,504+$4,857,438+37.72%
Jpmorgan Chase & Co0.00%639,929$12,106,209$16,190,204+$4,083,995+33.73%
Vanguard Fiduciary Trust Co0.00%657,588$12,079,892$16,636,976+$4,557,084+37.72%
Perceptive Advisors Llc0.17%581,980$10,690,973$14,724,094+$4,033,121+37.72%
Boothbay Fund Management, Llc0.19%541,058$9,939,235$13,688,767+$3,749,532+37.72%
Emerald Advisers, Llc0.23%537,328$9,870,715$13,594,398+$3,723,683+37.72%
Deutsche Bank Ag\0.00%482,875$8,870,414$12,216,738+$3,346,324+37.72%
Algert Global Llc0.11%482,237$8,858,694$12,200,596+$3,341,902+37.72%
Showing 50 of 212

Frequently asked questions about VRDN

  • Who are the largest institutional holders of VRDN?

    The largest institutional holders of VRDN reported in the latest SEC Form 13F filings include Fmr Llc, Blackrock, Inc., Bellevue Group Ag, Paradigm Biocapital Advisors Lp, and Kynam Capital Management, Lp. InsiderSet ranks institutional holders by their latest reported VRDN position.

  • What is VRDN institutional ownership?

    This page tracks VRDN positions reported by institutional investment managers through SEC Form 13F. VIRIDIAN THERAPEUTICS INC (VRDN) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own VRDN?

    InsiderSet currently tracks 212 institutional managers reporting VRDN holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of VRDN shareholders.

  • How much VRDN stock do institutions own?

    Institutional investment managers disclosed approximately $2.50B in VRDN holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was VRDN institutional ownership last updated?

    The latest VRDN institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional VRDN holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its VRDN position after the reporting date.

  • Are institutions buying or selling VRDN?

    Institutional buying and selling can be analyzed by comparing VRDN positions across consecutive 13F reporting periods. InsiderSet's VRDN Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View VRDN ownership changes.

  • How has VRDN institutional ownership changed over time?

    InsiderSet tracks VRDN institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.